Education
About Us
Working with TipRanks
Follow Us
Response Genetics (RGDXQ)
OTHER OTC:RGDXQ
Total Valuation
Response Genetics has a market cap or net worth of $39.00. The enterprise value is ―.
Market Cap$39.00
Enterprise Value―
Share Statistics
Response Genetics has 38,795,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding38,795,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Response Genetics’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee187.92K
Profits Per Employee-210.25K
Employee Count96
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Response Genetics is ―. Response Genetics’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Response Genetics had revenue of 18.04M and earned -20.18M in profits. Earnings per share was 0.00.
Revenue18.04M
Gross Profit3.94M
Operating Income-21.38M
Pretax Income-21.37M
Net Income-20.18M
EBITDA-19.67M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -13.09M and capital expenditures -51.42K, giving a free cash flow of -13.14M billion.
Operating Cash Flow-13.09M
Free Cash Flow-13.14M
Free Cash Flow per Share-0.34
Dividends & Yields
Response Genetics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Response Genetics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Response Genetics as a current ratio of ―, with Debt / Equity ratio of 19.30%
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Response Genetics has paid -1.18M in taxes.
Income Tax-1.18M
Effective Tax Rate―
Enterprise Valuation
Response Genetics EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Response Genetics has $1.73M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$9.21M billion.
Cash & Marketable Securities$1.73M
Total Debt$0.00
Net Cash-$9.21M
Net Cash Per Share-$0.24
Tangible Book Value Per Share―
Margins
Gross margin is 21.85%, with operating margin of ―, and net profit margin of ―.
Gross Margin21.85%
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Response Genetics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―